PMID- 25816734 OWN - NLM STAT- MEDLINE DCOM- 20160106 LR - 20180813 IS - 1590-3729 (Electronic) IS - 0939-4753 (Linking) VI - 25 IP - 5 DP - 2015 May TI - Lower bone turnover markers in metabolic syndrome and diabetes: the population-based Study of Health in Pomerania. PG - 458-63 LID - S0939-4753(15)00033-2 [pii] LID - 10.1016/j.numecd.2015.02.002 [doi] AB - BACKGROUND AND AIMS: Accumulating evidence demonstrates an important interaction between bone and energy metabolism. We aimed to study the associations of three bone turnover markers (BTM: osteocalcin, beta-crosslaps, procollagen type 1 N-terminal propeptide) as well as of 25-hydroxyvitamin D and parathyroid hormone with metabolic syndrome (MetS) or type 2 diabetes mellitus (T2DM) in a large population-based cohort. METHODS AND RESULTS: This cross-sectional study comprised 2671 adult men and women participating in the first follow-up of the population-based Study of Health in Pomerania (SHIP-1). Multivariable logistic regression analyses were performed to assess sex-specific associations between the BTMs, 25-hydroxyvitamin D or parathyroid hormone and metabolic disease. All models were adjusted for age, body mass index, smoking status, physical activity, estimated glomerular filtration rate and month of blood sampling. The models for women were further adjusted for menopausal status. Higher BTM or 25-hydroxyvitamin D concentrations were associated with significantly lower odds for metabolic disease, while there was no association between parathyroid hormone and MetS or T2DM. CONCLUSION: Our results contribute to the accumulating evidence of a cross-sectional association between high BTM or 25-hydroxyvitamin D concentrations and a lower prevalence of MetS or T2DM. Further research is necessary to evaluate the mechanisms underlying these results. CI - Copyright (c) 2015 Elsevier B.V. All rights reserved. FAU - Lerchbaum, E AU - Lerchbaum E AD - Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria; University Women's Hospital, Heidelberg, Germany. FAU - Schwetz, V AU - Schwetz V AD - Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria. FAU - Nauck, M AU - Nauck M AD - Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Germany. FAU - Volzke, H AU - Volzke H AD - Institute for Community Medicine, University Medicine Greifswald, Germany. FAU - Wallaschofski, H AU - Wallaschofski H AD - Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Germany. FAU - Hannemann, A AU - Hannemann A AD - Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Germany. Electronic address: anke.hannemann@uni-greifswald.de. LA - eng PT - Journal Article PT - Observational Study PT - Research Support, Non-U.S. Gov't DEP - 20150212 PL - Netherlands TA - Nutr Metab Cardiovasc Dis JT - Nutrition, metabolism, and cardiovascular diseases : NMCD JID - 9111474 RN - 0 (Biomarkers) RN - 0 (PTH protein, human) RN - 0 (Parathyroid Hormone) RN - 0 (Peptide Fragments) RN - 0 (Procollagen) RN - 0 (glutamyl-lysyl-alanyl-histidyl-aspartyl-glycyl-glycyl-arginine) RN - 0 (procollagen type I carboxy terminal peptide) RN - 104982-03-8 (Osteocalcin) RN - 1406-16-2 (Vitamin D) RN - 9007-34-5 (Collagen) RN - A288AR3C9H (25-hydroxyvitamin D) SB - IM MH - Adult MH - Aged MH - Biomarkers/blood MH - *Bone Remodeling MH - Cohort Studies MH - Collagen/*blood MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/blood/epidemiology/*metabolism MH - *Down-Regulation MH - Female MH - Follow-Up Studies MH - Germany/epidemiology MH - Humans MH - Male MH - Metabolic Syndrome/blood/epidemiology/*metabolism MH - Middle Aged MH - Osteocalcin/*blood MH - Parathyroid Hormone/blood MH - Peptide Fragments/*blood MH - Prevalence MH - Procollagen/*blood MH - Vitamin D/analogs & derivatives/blood MH - Young Adult OTO - NOTNLM OT - 25-hydroxyvitamin D OT - Beta-crosslaps OT - Osteocalcin OT - Procollagen type 1 N-terminal propeptide EDAT- 2015/03/31 06:00 MHDA- 2016/01/07 06:00 CRDT- 2015/03/31 06:00 PHST- 2014/08/15 00:00 [received] PHST- 2015/01/29 00:00 [revised] PHST- 2015/02/01 00:00 [accepted] PHST- 2015/03/31 06:00 [entrez] PHST- 2015/03/31 06:00 [pubmed] PHST- 2016/01/07 06:00 [medline] AID - S0939-4753(15)00033-2 [pii] AID - 10.1016/j.numecd.2015.02.002 [doi] PST - ppublish SO - Nutr Metab Cardiovasc Dis. 2015 May;25(5):458-63. doi: 10.1016/j.numecd.2015.02.002. Epub 2015 Feb 12.